06/03/2026
The 2026 ASCO Annual Meeting has officially wrapped up in Chicago, and VCU Massey Comprehensive Cancer Center was proud to be at the forefront of cutting-edge clinical oncology.
With our team represented on more than 30 poster presentations and abstracts, Massey researchers shared vital findings on the global stage. Our featured breakthroughs spanned multiple disciplines, including the impact of GLP-1 use on cancer outcomes, innovative microbiome modulation therapies for metastatic colorectal cancer, and advanced strategies to overcome immunotherapy resistance in solid tumors.
"To see the work of Massey researchers presented on this international stage not only reinforces our caliber as a research organization, but also provides incredible opportunities for collaboration and learning which we can then bring back to our catchment area," shared Monica L. Baskin, Ph.D., Massey's interim director.
Thank you to all of our incredible clinicians, researchers, and partners who represented us this week. Read the full recap of our presentations and abstracts here:
VCU Massey Comprehensive Cancer Center continued to be at the forefront for high-impact, cutting-edge research with a strong presence at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago from May 29-June 2.